Need a specific person's email?
Browse QED Therapeutics's employee directory (about 36 employees) and reveal verified emails free.
QED Therapeutics's most common email format is First.Last@qedtx.com (ex. John.Doe@qedtx.com), used for 93% of qedtx.com addresses. QED Therapeutics uses 4 email patterns.
| Format | Example | Share of qedtx.com |
|---|---|---|
| First.Last@qedtx.comMost common | John.Doe@qedtx.com | |
| FLast@qedtx.com | JDoe@qedtx.com | |
| FL@qedtx.com | JD@qedtx.com | |
| First@qedtx.com | John@qedtx.com |
Browse QED Therapeutics's employee directory (about 36 employees) and reveal verified emails free.
BiotechnologyCalifornia, United States11-50 Employees
QED Therapeutics is a biotechnology research company focused on developing treatment options for achondroplasia and advancing research into the condition's underlying biology. It is evaluating an investigational drug, infigratinib, with the aim of reducing overactivity of the FGFR3 receptor that leads to irregular bone growth. The firm operates from Palo Alto, California, as an affiliate of BridgeBio Pharma, placing it within a wider biopharma research ecosystem. In 2024, QED Therapeutics helped launch MyAchonJourney, an online platform to support individuals and families affected by achondroplasia. This initiative reflects ongoing activity in the space beyond its core research program.
Most common format
First.Last@qedtx.com
Example: John.Doe@qedtx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.